P35354 PGH2_HUMAN
Gene name: PTGS2
Protein name: Prostaglandin G/H synthase 2
List of molecules and drugs that target protein P35354
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P35354_DB00154 | DB00154 | Dihomo-gamma-linolenic acid | n/a | HOBAELRKJCKHQD-QNEBEIHSSA-N | CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O | |
2 | P35354_DB00159 | DB00159 | Icosapent | inhibitor | JAZBEHYOTPTENJ-JLNKQSITSA-N | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O | |
3 | P35354_DB00233 | DB00233 | Aminosalicylic acid | inhibitor | WUBBRNOQWQTFEX-UHFFFAOYSA-N | NC1=CC(O)=C(C=C1)C(O)=O | |
4 | P35354_DB00244 | DB00244 | Mesalazine | inhibitor | Ki(nM) = 10000.0 IC50(nM) = 7530.0 | KBOPZPXVLCULAV-UHFFFAOYSA-N | NC1=CC(C(O)=O)=C(O)C=C1 |
5 | P35354_DB00316 | DB00316 | Acetaminophen | inhibitor | Ki(nM) = 10000.0 IC50(nM) = 141000.0 | RZVAJINKPMORJF-UHFFFAOYSA-N | CC(=O)NC1=CC=C(O)C=C1 |
6 | P35354_DB00328 | DB00328 | Indomethacin | inhibitor | Ki(nM) = 130.0 IC50(nM) = 5.9 Kd(nM) = 92.0 | CGIGDMFJXJATDK-UHFFFAOYSA-N | COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O |
7 | P35354_DB00461 | DB00461 | Nabumetone | inhibitor | Ki(nM) = 10000.0 | BLXXJMDCKKHMKV-UHFFFAOYSA-N | COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2 |
8 | P35354_DB00465 | DB00465 | Ketorolac | inhibitor | Ki(nM) = 75.0 IC50(nM) = 120.0 | OZWKMVRBQXNZKK-UHFFFAOYSA-N | OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 |
9 | P35354_DB00469 | DB00469 | Tenoxicam | inhibitor | LZNWYQJJBLGYLT-UHFFFAOYSA-N | CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O | |
10 | P35354_DB00480 | DB00480 | Lenalidomide | negative modulator | GOTYRUGSSMKFNF-UHFFFAOYSA-N | NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O | |
11 | P35354_DB00482 | DB00482 | Celecoxib | inhibitor | Ki(nM) = 0.47 IC50(nM) = 0.52 Kd(nM) = 789.09 | RZEKVGVHFLEQIL-UHFFFAOYSA-N | CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F |
12 | P35354_DB00500 | DB00500 | Tolmetin | inhibitor | Ki(nM) = 820.0 | UPSPUYADGBWSHF-UHFFFAOYSA-N | CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1 |
13 | P35354_DB00533 | DB00533 | Rofecoxib | inhibitor | Ki(nM) = 310.0 IC50(nM) = 1.0 | RZJQGNCSTQAWON-UHFFFAOYSA-N | CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1 |
14 | P35354_DB00554 | DB00554 | Piroxicam | inhibitor | Ki(nM) = 170.0 IC50(nM) = 102000.0 | QYSPLQLAKJAUJT-UHFFFAOYSA-N | CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O |
15 | P35354_DB00573 | DB00573 | Fenoprofen | inhibitor | Ki(nM) = 5900.0 | RDJGLLICXDHJDY-UHFFFAOYSA-N | CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1 |
16 | P35354_DB00580 | DB00580 | Valdecoxib | inhibitor | Ki(nM) = 870.0 IC50(nM) = 5.0 | LNPDTQAFDNKSHK-UHFFFAOYSA-N | CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O |
17 | P35354_DB00586 | DB00586 | Diclofenac | inhibitor | IC50(nM) = 5.0 | DCOPUUMXTXDBNB-UHFFFAOYSA-N | OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl |
18 | P35354_DB00605 | DB00605 | Sulindac | inhibitor | MLKXDPUZXIRXEP-MFOYZWKCSA-N | CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O | |
19 | P35354_DB00712 | DB00712 | Flurbiprofen | inhibitor | Ki(nM) = 770.0 IC50(nM) = 10.0 | SYTBZMRGLBWNTM-UHFFFAOYSA-N | CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1 |
20 | P35354_DB00749 | DB00749 | Etodolac | inhibitor | Ki(nM) = 940.0 IC50(nM) = 2000.0 | NNYBQONXHNTVIJ-UHFFFAOYSA-N | CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1 |
21 | P35354_DB00784 | DB00784 | Mefenamic acid | inhibitor | Ki(nM) = 160.0 IC50(nM) = 2900.0 | HYYBABOKPJLUIN-UHFFFAOYSA-N | CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1 |
22 | P35354_DB00788 | DB00788 | Naproxen | inhibitor | IC50(nM) = 900.0 | CMWTZPSULFXXJA-VIFPVBQESA-N | COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O |
23 | P35354_DB00795 | DB00795 | Sulfasalazine | inhibitor | NCEXYHBECQHGNR-QZQOTICOSA-N | OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1 | |
24 | P35354_DB00812 | DB00812 | Phenylbutazone | inhibitor | VYMDGNCVAMGZFE-UHFFFAOYSA-N | CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1 | |
25 | P35354_DB00814 | DB00814 | Meloxicam | inhibitor | Ki(nM) = 230.0 IC50(nM) = 0.49 | ZRVUJXDFFKFLMG-UHFFFAOYSA-N | CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O |
26 | P35354_DB00821 | DB00821 | Carprofen | inhibitor | Ki(nM) = 4300.0 IC50(nM) = 100.0 | PUXBGTOOZJQSKH-UHFFFAOYSA-N | CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1 |
27 | P35354_DB00861 | DB00861 | Diflunisal | inhibitor | Ki(nM) = 8200.0 | HUPFGZXOMWLGNK-UHFFFAOYSA-N | OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1 |
28 | P35354_DB00870 | DB00870 | Suprofen | inhibitor | Ki(nM) = 8300.0 IC50(nM) = 2750.0 | MDKGKXOCJGEUJW-UHFFFAOYSA-N | CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1 |
29 | P35354_DB00936 | DB00936 | Salicylic acid | inhibitor | Ki(nM) = 10000.0 IC50(nM) = 40000.0 | YGSDEFSMJLZEOE-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1O |
30 | P35354_DB00939 | DB00939 | Meclofenamic acid | inhibitor | Ki(nM) = 200.0 IC50(nM) = 40.0 | SBDNJUWAMKYJOX-UHFFFAOYSA-N | CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1 |
31 | P35354_DB00945 | DB00945 | Acetylsalicylic acid | inhibitor | Ki(nM) = 7500.0 IC50(nM) = 2400.0 | BSYNRYMUTXBXSQ-UHFFFAOYSA-N | CC(=O)OC1=CC=CC=C1C(O)=O |
32 | P35354_DB00963 | DB00963 | Bromfenac | inhibitor | ZBPLOVFIXSTCRZ-UHFFFAOYSA-N | NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 | |
33 | P35354_DB00991 | DB00991 | Oxaprozin | inhibitor | Ki(nM) = 10000.0 IC50(nM) = 110.0 | OFPXSFXSNFPTHF-UHFFFAOYSA-N | OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1 |
34 | P35354_DB01009 | DB01009 | Ketoprofen | inhibitor | Ki(nM) = 240.0 IC50(nM) = 26.0 | DKYWVDODHFEZIM-UHFFFAOYSA-N | CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1 |
35 | P35354_DB01014 | DB01014 | Balsalazide | inhibitor | IPOKCKJONYRRHP-FMQUCBEESA-N | OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O | |
36 | P35354_DB01050 | DB01050 | Ibuprofen | inhibitor | Ki(nM) = 7200.0 IC50(nM) = 100.0 | HEFNNWSXXWATRW-UHFFFAOYSA-N | CC(C)CC1=CC=C(C=C1)C(C)C(O)=O |
37 | P35354_DB01283 | DB01283 | Lumiracoxib | inhibitor | Ki(nM) = 320.0 IC50(nM) = 7.0 | KHPKQFYUPIUARC-UHFFFAOYSA-N | CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1 |
38 | P35354_DB01397 | DB01397 | Magnesium salicylate | inhibitor | MQHWFIOJQSCFNM-UHFFFAOYSA-L | [Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O | |
39 | P35354_DB01399 | DB01399 | Salsalate | inhibitor | Ki(nM) = 10000.0 | WVYADZUPLLSGPU-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O |
40 | P35354_DB01401 | DB01401 | Choline magnesium trisalicylate | inhibitor | Ki(nM) = 10000.0 | FQCQGOZEWWPOKI-UHFFFAOYSA-K | [Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O |
41 | P35354_DB01419 | DB01419 | Antrafenine | inhibitor | NWGGKKGAFZIVBJ-UHFFFAOYSA-N | FC(F)(F)C1=CC(=CC=C1)N1CCN(CCOC(=O)C2=CC=CC=C2NC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)CC1 | |
42 | P35354_DB01435 | DB01435 | Antipyrine | inhibitor | VEQOALNAAJBPNY-UHFFFAOYSA-N | CN1N(C(=O)C=C1C)C1=CC=CC=C1 | |
43 | P35354_DB01600 | DB01600 | Tiaprofenic acid | inhibitor | GUHPRPJDBZHYCJ-UHFFFAOYSA-N | CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1 | |
44 | P35354_DB01628 | DB01628 | Etoricoxib | inhibitor | Ki(nM) = 69.0 IC50(nM) = 70.0 | MNJVRJDLRVPLFE-UHFFFAOYSA-N | CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O |
45 | P35354_DB02266 | DB02266 | Flufenamic acid | n/a | IC50(nM) = 16.0 | LPEPZBJOKDYZAD-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F |
46 | P35354_DB02709 | DB02709 | Resveratrol | inhibitor | Ki(nM) = 10000.0 IC50(nM) = 750.0 | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 |
47 | P35354_DB03477 | DB03477 | 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole | n/a | IC50(nM) = 9.3 | OYZKFVIVPRQRQQ-UHFFFAOYSA-N | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Br)C=C1)C(F)(F)F |
48 | P35354_DB03866 | DB03866 | Prostaglandin G2 | n/a | SGUKUZOVHSFKPH-YNNPMVKQSA-N | [H][C@@](CCCCC)(OO)\C=C\[C@@]1([H])[C@@]2([H])C[C@]([H])(OO2)[C@]1([H])C\C=C/CCCC(O)=O | |
49 | P35354_DB04552 | DB04552 | Niflumic acid | inhibitor | Ki(nM) = 5400.0 | JZFPYUNJRRFVQU-UHFFFAOYSA-N | OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1 |
50 | P35354_DB04725 | DB04725 | Licofelone | n/a | IC50(nM) = 370.0 | UAWXGRJVZSAUSZ-UHFFFAOYSA-N | CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1 |
51 | P35354_DB04743 | DB04743 | Nimesulide | inhibitor | Ki(nM) = 180.0 IC50(nM) = 15.0 | HYWYRSMBCFDLJT-UHFFFAOYSA-N | CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O |
52 | P35354_DB05095 | DB05095 | Cimicoxib | n/a | IC50(nM) = 5.0 | KYXDNECMRLFQMZ-UHFFFAOYSA-N | COC1=C(F)C=C(C=C1)C1=C(Cl)N=CN1C1=CC=C(C=C1)S(N)(=O)=O |
53 | P35354_DB06725 | DB06725 | Lornoxicam | inhibitor | WLHQHAUOOXYABV-UHFFFAOYSA-N | CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O | |
54 | P35354_DB06736 | DB06736 | Aceclofenac | inhibitor | MNIPYSSQXLZQLJ-UHFFFAOYSA-N | OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl | |
55 | P35354_DB06802 | DB06802 | Nepafenac | inhibitor | QEFAQIPZVLVERP-UHFFFAOYSA-N | NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N | |
56 | P35354_DB08439 | DB08439 | Parecoxib | inhibitor | TZRHLKRLEZJVIJ-UHFFFAOYSA-N | CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1 | |
57 | P35354_DB08910 | DB08910 | Pomalidomide | inhibitor | UVSMNLNDYGZFPF-UHFFFAOYSA-N | NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | |
58 | P35354_DB09061 | DB09061 | Cannabidiol | inhibitor | QHMBSVQNZZTUGM-ZWKOTPCHSA-N | CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1 | |
59 | P35354_DB09212 | DB09212 | Loxoprofen | antagonist | IC50(nM) = 13500.0 | YMBXTVYHTMGZDW-UHFFFAOYSA-N | CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1 |
60 | P35354_DB09213 | DB09213 | Dexibuprofen | inhibitor | IC50(nM) = 730.0 | HEFNNWSXXWATRW-JTQLQIEISA-N | CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O |
61 | P35354_DB09214 | DB09214 | Dexketoprofen | antagonist | IC50(nM) = 27.0 | DKYWVDODHFEZIM-NSHDSACASA-N | [H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1 |
62 | P35354_DB09215 | DB09215 | Droxicam | inhibitor | OEHFRZLKGRKFAS-UHFFFAOYSA-N | CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O | |
63 | P35354_DB09216 | DB09216 | Tolfenamic acid | antagonist | IC50(nM) = 880.0 | YEZNLOUZAIOMLT-UHFFFAOYSA-N | CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O |
64 | P35354_DB09217 | DB09217 | Firocoxib | n/a | IC50(nM) = 140.0 | FULAPETWGIGNMT-UHFFFAOYSA-N | CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O |
65 | P35354_DB09285 | DB09285 | Morniflumate | n/a | LDXSPUSKBDTEKA-UHFFFAOYSA-N | FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1 | |
66 | P35354_DB09288 | DB09288 | Propacetamol | antagonist | QTGAJCQTLIRCFL-UHFFFAOYSA-N | CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1 | |
67 | P35354_DB09295 | DB09295 | Talniflumate | antagonist | ANMLJLFWUCQGKZ-UHFFFAOYSA-N | FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1 | |
68 | P35354_DB11071 | DB11071 | Phenyl salicylate | antagonist | ZQBAKBUEJOMQEX-UHFFFAOYSA-N | OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 | |
69 | P35354_DB11079 | DB11079 | Trolamine salicylate | inhibitor | UEVAMYPIMMOEFW-UHFFFAOYSA-N | OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O | |
70 | P35354_DB11201 | DB11201 | Menthyl salicylate | antagonist | SJOXEWUZWQYCGL-DVOMOZLQSA-N | CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O | |
71 | P35354_DB11323 | DB11323 | Glycol salicylate | antagonist | LVYLCBNXHHHPSB-UHFFFAOYSA-N | OCCOC(=O)C1=CC=CC=C1O | |
72 | P35354_DB11327 | DB11327 | Dipyrithione | n/a | ZHDBTKPXEJDTTQ-UHFFFAOYSA-N | [O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-] | |
73 | P35354_DB11752 | DB11752 | Bryostatin 1 | inducer | MJQUEDHRCUIRLF-TVIXENOKSA-N | [H][C@]12C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@]3([H])C\C(C[C@@]([H])(O3)\C=C\C(C)(C)[C@]3(O)O[C@@]([H])(C\C(=C/C(=O)OC)[C@@H]3OC(=O)\C=C\C=C\CCC)C[C@@]([H])(OC(=O)C[C@H](O)C1)[C@@H](C)O)=C\C(=O)OC)O2 | |
74 | P35354_DB13167 | DB13167 | Alclofenac | antagonist | ARHWPKZXBHOEEE-UHFFFAOYSA-N | OC(=O)CC1=CC(Cl)=C(OCC=C)C=C1 | |
75 | P35354_DB13346 | DB13346 | Bufexamac | inhibitor | MXJWRABVEGLYDG-UHFFFAOYSA-N | CCCCOC1=CC=C(CC(=O)NO)C=C1 | |
76 | P35354_DB13501 | DB13501 | Bendazac | n/a | BYFMCKSPFYVMOU-UHFFFAOYSA-N | OC(=O)COC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12 | |
77 | P35354_DB13783 | DB13783 | Acemetacin | antagonist | FSQKKOOTNAMONP-UHFFFAOYSA-N | COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O | |
78 | P35354_DB14011 | DB14011 | Nabiximols | inhibitor | SSNHGLKFJISNTR-DYSNNVSPSA-N | [H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C |